Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Solid Biosciences faces lawsuits over Duchenne drug

This week: Solid Biosciences Inc. faces multiple filings over claims it misled investors and bone marrow-based cell therapy shows promise in Friedreich’s ataxia.

Please sign in or register for FREE

No comments yet.